We serve Chemical Name:2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy CAS:512177-95-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy](https://a.dearchem.com/CAS2/512177-95-6.png)
Chemical Name:2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy
CAS.NO:512177-95-6
Synonyms:4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one;4-acetyl-1-(4-chloro-3-ethylphenyl)-5-cyclohexyl-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one
Molecular Formula:C20H22ClNO5
Molecular Weight:391.84500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:560.355ºC at 760 mmHg
Density:1.408g/cm3
Index of Refraction:1.629
PSA:76.07000
Exact Mass:391.11900
LogP:3.45460
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-acetyl-1-(4-chloro-3-ethylphenyl)-5-cyclohexyl-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one Use and application,4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one technical grade,usp/ep/jp grade.
Related News: AstraZeneca acquired global rights to anifrolumab through an exclusive license and collaboration agreement with Medarex, Inc. in 2004. Medarex was acquired by Bristol-Myers Squibb in 2009. peliomycin manufacturers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 3-Fluoro-5-methoxybiphenyl-3-carboxylic acid suppliers This scheme also stipulates minimum domestic value addition in different target segments. Fermentation based products should have at least 90% and chemical synthesis based products should have at least 70% domestic content to qualify for the benefits. 2-(thiophen-3-ylmethylsulfanyl)acetic acid vendor & factory.
